Point72 Hong Kong LTD Abb Vie Inc. Put Options Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $429,472 - $492,576	-3,200 Reduced 23.7%	10,300 $1.38 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $233,954 - $297,432	-1,700 Reduced 11.18%	13,500 $2.07 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $1.19 Million - $1.47 Million	9,000 Added 145.16%	15,200 $2.46 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $773,496 - $978,696	-7,200 Reduced 53.73%	6,200 $839,000
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $808,640 - $917,928	7,600 Added 131.03%	13,400 $1.45 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $347,193 - $386,793	-3,300 Reduced 36.26%	5,800 $653,000
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $2.02 Million - $2.22 Million	-19,700 Reduced 68.4%	9,100 $985,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $2.32 Million - $3.13 Million	28,800 New	28,800 $3.09 Million

3,808

1.27B

13M

9.94M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.